Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | MME | P08473 | 4/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | CPA1 | P15085 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | CTRB1 | P17538 | 5/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30159126 | 1.00 | DPP4 (0.48) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL9701067 | 1.00 | DPP4 (0.48) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL29358853 | 1.00 | DPP4 (0.48) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL31474793 | 1.00 | DPP4 (0.48) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL9242218 | 1.00 | DPP4 (0.48) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL8695992 | 1.00 | DPP4 (0.48) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL30997435 | 1.00 | DPP4 (0.48) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL10620393 | 1.00 | DPP4 (0.48) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL9242204 | 1.00 | DPP4 (0.48) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL29349982 | 1.00 | DPP4 (0.48) | DPP4MMEACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118173765-A | Composite lithium iron manganese phosphate positive electrode material, and preparation method and application thereof | 曲靖市德方纳米科技有限公司 | 2024-06-11 | — | — | CN | claimed |
| US-20260146063-A1 | CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260008816-A1 | CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2026-01-08 | — | — | US | disclosed |
| US-20250332293-A1 | METHOD FOR MANUFACTURING BIOCOMPATIBLE NANOPARTICLES WITH A PEPTIDE CORE EXHIBITING SECOND- AND THIRD-HARMONIC SIGNAL GENERATION | Pantazis, Periklis (CH) | 2025-10-30 | — | — | US | disclosed |
| US-12454552-B2 | Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2025-10-28 | — | — | US | disclosed |
| EP-4596689-A1 | ENZYME AGENT AND USE THEREOF | Amano Enzyme Inc. (JP) | 2025-08-06 | — | — | EP | disclosed |
| CN-118638817-A | Application of tomato SlPIF b gene in regulation and control of tomato fruit coloring and ripening | 沈阳农业大学 | 2024-09-13 | — | — | CN | disclosed |
| US-20240230663-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR PROFILING OR PREDICTING AN IMMUNE RESPONSE | AVAIL BIO INC (US) | 2024-07-11 | — | — | US | disclosed |
| CN-118173765-A | Composite lithium iron manganese phosphate positive electrode material, and preparation method and application thereof | 曲靖市德方纳米科技有限公司 | 2024-06-11 | — | — | CN | disclosed |
| WO-2024071388-A1 | ENZYME AGENT AND USE THEREOF | 天野エンザイム株式会社 | 2024-04-04 | — | — | WO | disclosed |
| CN-110546155-B | Process for producing peptide | 浜理药品工业株式会社 | 2023-06-23 | — | — | CN | disclosed |
| US-20220306693-A1 | CYCLIC CELL PENETRATING PEPTIDES COMPRISING BETA-HAIRPIN MOTIFS AND METHODS OF MAKING AND USING THEREOF | OHIO STATE INNOVATION FOUNDATION | 2022-09-29 | — | — | US | disclosed |
| US-11352394-B2 | Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2022-06-07 | — | — | US | disclosed |
| US-11084846-B2 | Method for producing peptide | HAMARI CHEMICALS, LTD. (JP) | 2021-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352394-B2 | Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof | VIP, LNPEP, IAPP | DPP4 1670/4885MME 417/4885ACE 3502/4885 |
| US-20260008816-A1 | CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF | SLC3A2, SPPL2B, SLC7A1 | DPP4 409/4885MME 2100/4885ACE 3419/4885 |
| US-20260146063-A1 | CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF | VIP, SLC7A1, SLC6A15 | DPP4 523/4885MME 753/4885ACE 1946/4885 |
| US-20220306693-A1 | CYCLIC CELL PENETRATING PEPTIDES COMPRISING BETA-HAIRPIN MOTIFS AND METHODS OF MAKING AND USING THEREOF | CHN2, TAP2, VIP | DPP4 1003/4885MME 1642/4885ACE 3325/4885 |
| US-11084846-B2 | Method for producing peptide | VIP, SCTR, SSTR5 | DPP4 745/4885MME 500/4885ACE 991/4885 |
| US-12454552-B2 | Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof | CHN2, TAP2, VIP | DPP4 1003/4885MME 1642/4885ACE 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.